Related Experiment Videos
Exploring heart lymphatics in local drug delivery
Peter A Altman1, Richard Sievers, Randall Lee
1BioCardia, Inc, South San Francisco, California 94080, USA. paltman@biocardia.com
Lymphatic Research and Biology
|December 31, 2004
Summary
Intramyocardial delivery (IMD) of small microspheres (<200 nm) distributes agents through cardiac lymphatics, while larger microspheres (≥15,000 nm) remain localized, informing cell and gene therapy strategies.
Area of Science:
- Cardiovascular Research
- Biomedical Engineering
- Regenerative Medicine
Background:
- Local intramyocardial delivery (IMD) is crucial for cell and gene therapies targeting heart failure and coronary artery disease.
- Understanding agent migration post-IMD is vital for optimizing therapeutic efficacy and safety.
- Lymphatic pathways represent a significant route for agent redistribution from the myocardium.
Purpose of the Study:
- To characterize the migration patterns of locally delivered agents within the heart.
- To investigate the role of lymphatic vessels in the redistribution of intramyocardial injections.
- To determine the influence of particle size on the localization of intramyocardial therapies.
Main Methods:
- Injection of fluorescent microspheres (20 nm to 15,000 nm) into the left ventricular wall of rats (N=83).
- Utilizing fluorescent microscopy to visualize and quantify microsphere migration patterns.
- Assessing the presence of microspheres in cardiac lymph nodes and lymphatic networks.
Main Results:
- Microspheres <200 nm widely distributed within cardiac lymphatics and the ventricular wall.
- Cardiac lymph nodes were identified only with 20 nm and 100 nm microsphere deliveries.
- Microspheres ≥15,000 nm showed no significant migration from the injection site.
Conclusions:
- Tortuous lymphatic pathways facilitate the migration of small agents from intramyocardial delivery sites.
- IMD's lymphatic role may support therapeutic angiogenesis and collateral formation.
- The retention of large particles suggests IMD's potential for localized, long-term cell therapy delivery.